Cisplatin in cancer therapy: Molecular mechanisms of action

Article Properties
Cite
Dasari, Shaloam, and Paul Bernard Tchounwou. “Cisplatin in Cancer Therapy: Molecular Mechanisms of Action”. European Journal of Pharmacology, vol. 740, 2014, pp. 364-78, https://doi.org/10.1016/j.ejphar.2014.07.025.
Dasari, S., & Bernard Tchounwou, P. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364-378. https://doi.org/10.1016/j.ejphar.2014.07.025
Dasari S, Bernard Tchounwou P. Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology. 2014;740:364-78.
Refrences
Refrences Analysis
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 88 is the most frequently represented among the references in this article. It primarily includes studies from Cancer The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The first research to cite this article was titled Induction of Cell Cycle Arrest and Apoptosis by Physcion, an Anthraquinone Isolated From Rhubarb (Rhizomes of Rheum tanguticum), in MDA-MB-231 Human Breast Cancer Cells and was published in 2014. The most recent citation comes from a 2024 study titled Induction of Cell Cycle Arrest and Apoptosis by Physcion, an Anthraquinone Isolated From Rhubarb (Rhizomes of Rheum tanguticum), in MDA-MB-231 Human Breast Cancer Cells . This article reached its peak citation in 2022 , with 546 citations.It has been cited in 1,004 different journals, 23% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 153 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year